Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05672095
What this trial is testing

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00003967
What this trial is testing

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)WithdrawnNCT01131039
What this trial is testing

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube NeoplasmsOvarian CancerPrimary Peritoneal
Emory University
Testing effectiveness (Phase 2)Study completedNCT00377429
What this trial is testing

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Who this might be right for
Ovarian Cancer
Neovii Biotech 47
Early research (Phase 1)Study completedNCT03023319
What this trial is testing

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungMesotheliomaBladder Cancer+5 more
Nagla Abdel Karim 6
Testing effectiveness (Phase 2)Study completedNCT02948075
What this trial is testing

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Ovarian Cancer
NewVac LLC 31
Testing effectiveness (Phase 2)WithdrawnNCT04510584
What this trial is testing

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Who this might be right for
Ovarian Endometrioid TumorFallopian Tube CancerPrimary Peritoneal Cancer+1 more
University Health Network, Toronto
Not applicableStudy completedNCT01242436
What this trial is testing

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

Who this might be right for
Ovarian CancerPeritoneal Metastasis
Universitaire Ziekenhuizen KU Leuven 50
Testing effectiveness (Phase 2)Study completedNCT01610206
What this trial is testing

Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Linda R Duska 148
Not applicableUnknownNCT02861872
What this trial is testing

Intra-peritoneal Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsImmune ToleranceNeoplasms+1 more
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT02567253
What this trial is testing

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
University Hospital, Ghent 56
Early research (Phase 1)Study completedNCT00006041
What this trial is testing

Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00698451
What this trial is testing

Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)Ended earlyNCT04729387
What this trial is testing

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 358
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableUnknownNCT01539785
What this trial is testing

Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

Who this might be right for
First Recurrence of Ovarian Cancer
Catholic University of the Sacred Heart 158
Not applicableWithdrawnNCT04368130
What this trial is testing

SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+3 more
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00004081
What this trial is testing

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Beth Israel Deaconess Medical Center 30
Next Page